
Seismic Therapeutic
The Machine Learning Immunology Company
Cambridge, United States · Founded 2010 · $247.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2010
- Business Model
- B2B
- Website
- seismictx.com
- Total Funding
- $247.0M
- Last Round
- $25.0M Extension RoundJul 2025
- Rounds
- 3
About
Seismic Therapeutic is a clinical-stage immunology company applying proprietary machine learning to discover and develop novel biologic medicines for autoimmune and inflammatory diseases. Its IMPACT platform integrates ML with structural biology, protein engineering, and translational immunology to enable parallel biologics discovery across dysregulated adaptive immunity targets. The company has a growing pipeline of biologic candidates advancing through clinical development.
Summary
Seismic Therapeutic is a Biotech company based in Cambridge, United States, founded in 2010. It has raised $247.0M in total across 3 rounds, most recently a $25.0M Extension Round round in Jul 2025. Investors include Bessemer VP, Lightspeed VP and Amgen.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Clinical-stage precision medicines company using protein-motion-driven drug discovery to design s...
Biotechnology company that discovers and develops medicines for serious, life-threatening disease...

